Charity–academia partnership receives success payment for cancer epigenetics research
Cancer Research Technology (an arm of Cancer Research UK; London, UK) has received a success payment from GlaxoSmithKline (Brentford, UK) as reward for its collaborative research efforts developing molecules targeting cancer epigenetics.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.